Showing results (1871-1880 of 5,608) with videos related to

Sort By:
Pageof 561
Nuclear Medicine Communications|November 29, 2016
Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysisRuimin Wang, Baixuan Xu, Zhe Guo, et al.
Nuclear Medicine Communications|May 3, 2014
Expression of miR-100 and RBSP3 in FTC-133 cells after exposure to 131IShining Zhang, Baoping Deng, Yuanyuan Zhang, et al.
Nuclear Medicine Communications|December 7, 2016
The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centersMohamad Haidar, Ali Shamseddine, Emmanouil Panagiotidis, et al.
Nuclear Medicine Communications|October 19, 2016
Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studiesBert-Ram Sah, Paul Stolzmann, Gaspar Delso, et al.
Nuclear Medicine Communications|December 24, 2016
The cardiosplenic axis: another obscure pathophysiological function of the spleen and its investigation using molecular imagingAlexander Dunford, Georgia Keramida, Constantinos D Anagnostopoulos, et al.
Nuclear Medicine Communications|March 15, 2017
Value of second-opinion review of outside institution PET-CT examinationsGary A Ulaner, Lorenzo Mannelli, Mark Dunphy
Nuclear Medicine Communications|March 15, 2017
67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in miceZhao-Hui Jin, Takako Furukawa, Tomoyuki Ohya, et al.
Nuclear Medicine Communications|April 7, 2017
Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult malesGil Ho Lee, Jai Hyuen Lee
Nuclear Medicine Communications|April 15, 2017
Initial experience with real-time hybrid single-photon emission computed tomography/computed tomography-guided percutaneous transthoracic needle biopsyQian Hua, Xiangyun Zhu, Lei Zhang, et al.
Nuclear Medicine Communications|April 15, 2017
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patientsLaura Evangelista, Anna R Cervino, Silvia Michieletto, et al.
Pageof 561